MP
MapLight Therapeutics, Inc.
MPLT · NASDAQ
$10.92 -2.59% (-$0.29)
1M -2.59%
Market Cap $480.4M
P/E Ratio -
Div. Yield -
ROE 63.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.38x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 180.05%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 69.35%
ROE 63.84%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 16.52x
Int. coverage N/A
Stability
30 /100
Unstable Beta 2.57x
EPS volatility 30.04%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o MPLT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher A. Kroeger
Employees
133
Headquarters
Redwood City
Nadchodzące wydarzenia
03 GRU
Earnings
Upcoming earnings report